Characterisation of the proximal airway squamous metaplasia induced by chronic tobacco smoke exposure in spontaneously hypertensive rats

Respiratory Research

Volumn 10, Issue , 2009, Pages

  Bolton, Sarah J ^a   Pinnion, Kate ^a   Oreffo, Victor ^a   Foster, Martyn ^a   Pinkerton, Kent E ^b  

^a ASTRAZENECA   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CC10 PROTEIN; CD31 ANTIGEN; CYTOKERATIN 10; CYTOKERATIN 13; CYTOKERATIN 18; CYTOKERATIN 4; CYTOKERATIN 5; CYTOKERATIN 6; CYTOKERATIN 8; KI 67 ANTIGEN; LUNG SURFACTANT; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN; PROTEIN P40; PROTEIN P63; SURFACTANT D; TOBACCO SMOKE; UNCLASSIFIED DRUG; CLARA CELL SECRETORY PROTEIN; KA13 PROTEIN, RAT; KRT13 PROTEIN, HUMAN; SURFACTANT PROTEIN D; UTEROGLOBIN;

AIRWAY SQUAMOUS METAPLASIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL CELL; BRONCHIOLE; BRONCHUS; CELL DIFFERENTIATION; CELL PROLIFERATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; EXPOSURE; HUMAN; HUMAN TISSUE; HUMAN VERSUS ANIMAL COMPARISON; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS CELL; LUNG ALVEOLUS MACROPHAGE; LUNG PARENCHYMA; NONHUMAN; PHENOTYPE; RAT; RESPIRATORY TRACT DISEASE; SECRETORY CELL; SQUAMOUS CELL; SQUAMOUS CELL METAPLASIA; TURNOVER TIME; ANIMAL; DISEASE MODEL; DRUG EFFECT; EPITHELIUM CELL; HYPERTENSION; LUNG; METABOLISM; METAPLASIA; PATHOLOGY; PHOSPHORYLATION; SMOKING; SPECIES DIFFERENCE; SPONTANEOUSLY HYPERTENSIVE RAT; TIME;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; HUMANS; HYPERTENSION; IMMUNOHISTOCHEMISTRY; KERATIN-13; KI-67 ANTIGEN; LUNG; METAPLASIA; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHENOTYPE; PHOSPHORYLATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; RATS; RATS, INBRED SHR; SMOKING; SPECIES SPECIFICITY; TIME FACTORS; UTEROGLOBIN;

EID: 73949135486     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-10-118     Document Type: Article

References (44)

1. Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. The Lancet 2004, 364:709-721.
2. Kim V, Rogers TJ, Criner GJ. New Concepts in the Pathobiology of Chronic Obstructive Pulmonary Disease. Proc Am Thorac Soc 2008, 5:478-485. 2645323, 18453359, 10.1513/pats.200802-014ET.
3. Lapperre T, Sont J, van Schadewijk A, Gosman M, Postma D, Bajema I, Timens W, Mauad T, Hiemstra P, . the GLUCOLD Study Group Smoking cessation and bronchial epithelial remodelling in COPD: a cross-sectional study. Resp Res 2007, 8:85. the GLUCOLD Study Group.
4. Puchelle E, Zahm JM, Tournier JM, Coraux C. Airway Epithelial Repair, Regeneration, and Remodeling after Injury in Chronic Obstructive Pulmonary Disease. Proc Am Thorac Soc 2006, 3:726-733. 10.1513/pats.200605-126SF, 17065381.
5. Rennard SI. Inflammation and Repair Processes in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 1999, 160:12S-16.
6. Araya J, Cambier S, Markovics JA, Wolters P, Jablons D, Hill A, Finkbeiner W, Jones K, Broaddus VC, Sheppard D, et al. Squamous metaplasia amplifies pathologic epithelial-mesenchymal interactions in COPD patients. J Clin Invest 2007, 117:3551-3562. 2040320, 17965775, 10.1172/JCI32526.
7. Broers JLV, de Leij L, Klein Rot M, ter Haar A, Lane B, Leigh IM, Wagenaar S, Vooijs GP, Ramaekers FCS. Expression of intermediate filament proteins in fetal and adult human lung tissues. Differentiation 1989, 40:119-128. 10.1111/j.1432-0436.1989.tb00821.x, 2474472.
8. Kasper M, Rudolf T, Verhofstad AAJ, Schuh D, Muller M. Heterogeneity in the immunolocalization of cytokeratin-specific monoclonal antibodies in the rat lung: evaluation of three different alveolar epithelial cell types. Histochem 1993, 100:65-71.
9. Broers JLV, Ramaekers FCS, Rot MK, Oostendorp T, Huysmans A, van Muijen GNP, Wagenaar SS, Vooijs GP. Cytokeratins in Different Types of Human Lung Cancer as Monitored by Chain-specific Monoclonal Antibodies. Cancer Res 1988, 48:3221-3229.
10. Schlage WK, Bulles H, Friedrichs D, Kuhn M, Teredesai A. Cytokeratin expression patterns in the rat respiratory tract as markers of epithelial differentiation in inhalation toxicology. I. Determination of normal cytokeratin expressino patterns in nose, larynx, trachea and lung. Toxicol Pathol 1998, 26:324-343. 10.1177/019262339802600307, 9608639.
11. Kal HB, van Berkel AH, Broers JLV, Klein JC, Mijnheere EP, Roholl PJM, Ramaekers FCS. Cytokeratins expressed in experimental rat bronchial carcinomas. Int J Cancer 1993, 53:506-513. 10.1002/ijc.2910530325, 7679092.
12. Weinstein MH, Signoretti S, Loda M. Diagnostic Utility of Immunohistochemical Staining for p63, a Sensitive Marker of Prostatic Basal Cells. Mod Pathol 2002, 15:1302-1308. 10.1097/01.MP.0000038460.95912.6E, 12481011.
13. Barbieri CE, Pietenpol JA. p63 and epithelial biology. Exp Cell Res 2006, 312:695-706. 10.1016/j.yexcr.2005.11.028, 16406339.
14. Murray-Zmijewski F, Lane DP, Bourdon JC. p53//p63//p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress. Cell Death Differ 2006, 13:962-972. 10.1038/sj.cdd.4401914, 16601753.
15. Chilosi M, Poletti V, Murer B, Lestani M, Cancellieri A, Montagna L, Piccoli P, Cangi G, Semenzato G, Doglioni C. Abnormal re-epithelialization and lung remodelling in idiopathic pulmonary fibrosis: the role of dN-p63. Lab Invest 2002, 82:1335-1345.
16. Hibi K, Trink B, Patturajan M, Westra WH, Caballero OL, Hill DE, Ratovitski EA, Jen J, Sidransky D. AIS is an oncogene amplified in squamous cell carcinoma. Proc Natl Acad Sci USA 2000, 97:5462-5467. 25851, 10805802, 10.1073/pnas.97.10.5462.
17. Senoo M, Tsuchiya I, Matsumura Y, Mori T, Saito Y, Kato H, Okamoto T, Habu S. Transcriptional dysregulation of the p73L/p63/p51/p40/KET gene in human squamous cell carcinomas: expression of Np73L, a novel dominant-negative isoform, and loss of expression of the potential tumour suppressor p51. Br J Cancer 2001, 84:1235-1241. 2363892, 11336476, 10.1054/bjoc.2000.1735.
18. Haschek AM, Rousseaux CG. Fundamentals of Toxicologic Pathology 1998, Academic Press.
19. Hahn FF, Gigliotti AP, Hutt JA, March TH, Mauderly JL. A review of the histopathology of cigarette smoke-induced lung cancer in rats and mice. Int J Toxicol 2007, 26:307-313. 10.1080/10915810701483450, 17661221.
20. Walker NJ, Yoshizawa K, Miller RA, Brix AE, Sells DM, Jokinen MP, Wyde ME, Easterling M, Nyska A. Pulmonary lesions in female Harlan Sprague-Dawley rats following two year oral treatment with dioxin-like compounds. Toxicol Pathol 2007, 35:880-889. 2633090, 18098034, 10.1080/01926230701748396.
21. Mohr U, Ernst H, Roller M, Pott F. Pulmonary tumor types induced in Wistar rats of the so-called "19-dust study". Exp Toxicol Path 2006, 58:13-20.
22. Zhong CY, Zhou YM, Douglas GC, Witschi H, Pinkerton KE. MAPK/AP-1 signal pathway in tobacco smoke-induced cell proliferation and squamous metaplasia in the lungs of rats. Carcinogenesis 2005, 26:2187-2195. 10.1093/carcin/bgi189, 16051644.
23. Kodavanti UP, Costa DL. Rodent models of susceptibility: what is their place in inhalation toxicology?. Resp Physiol 2001, 128:57-70.
24. Kodavanti UP, Schladweiler MC, Ledbetter AD, Ortuno RV, Suffia M, Evansky P, Richards JH, Jaskot RH, Thomas R, Karoly E, et al. The Spontaneously Hypertensive Rat: An Experimental Model of Sulfur Dioxide-Induced Airways Disease. Toxicol Sci 2006, 94:193-205. 10.1093/toxsci/kfl087, 16929007.
25. Yu B, Kodavanti UP, Takeuchi M, Witschi H, Pinkerton KE. Acute Tobacco Smoke-Induced Airways Inflammation in Spontaneously Hypertensive Rats. Inhal Toxicol 2008, 20:623-633. 10.1080/08958370701861538, 18464051.
26. Pravenec M, Landa V, Zídek V, Musilová A, Kazdová L, Qi N, Wang J, St Lezin E, Kurtz T. Transgenic expression of CD36 in the spontaneously hypertensive rat is associated with amelioration of metabolic disturbances but has no effect on hypertension. Physiol Res 2003, 52:681-688.
27. Vaughan P, Waller DA. Surgical treatment of pulmonary emphysema. Surgery (Oxford) 2005, 23:435-438.
28. Wilson E, Jackson S, Cruwys S, Kerry P. An evaluation of the immunohistochemistry benefits of boric acid antigen retrieval on rat decalcified joint tissues. J Immunol Meth 2007, 322:137-142.
29. Zhong CY, Zhou YM, Pinkerton KE. NF-[kappa]B inhibition is involved in tobacco smoke-induced apoptosis in the lungs of rats. Toxicol Appl Pharmacol 2008, 230:150-158. 2495769, 18355884, 10.1016/j.taap.2008.02.005.
30. Hermans C, Knoops B, Wiedig M, Arsalane K, Toubeau G, Falmagne P, Bernard A. Clara cell protein as a marker of Clara cell damage and bronchoalveolar blood barrier permeability. Eur Respir J 1999, 13:1014-1021. 10.1034/j.1399-3003.1999.13e14.x, 10414398.
31. Pinkerton KE, Dodge DE, Cederdahl-Demmler J, Wong VJ, Peake J, Haselton CJ, Mellick PW, Singh G, Plopper CG. Differentiated bronchiolar epithelium in alveolar ducts of rats exposed to ozone for 20 months. Am J Pathol 1993, 142:947-956. 1886801, 8456949.
32. Van Miert E, Dumont X, Bernard A. CC16 as a amarker of lung epithelial hyperpermeability in an acute model of rats exposed to mainstream cigarette smoke. Toxicol Letts 2005, 159:115-123.
33. Bolton SJ, Pinnion K, Marshall CV, Wilson E, Barker J, Oreffo V, Foster ML. Changes in Clara Cell 10 kDa Protein (CC10)-positive cell distribution in acute lung injury following repeated lipopolysaccharide challenge in the rat. Toxicol Pathol 2008, 36:440-448. 10.1177/0192623308315357, 18420837.
34. Zhong CY, Zhou YM, Pinkerton KE. NF-[kappa]B inhibition is involved in tobacco smoke-induced apoptosis in the lungs of rats. Toxicol Appl Pharmacol 2008, 230:150-158. 2495769, 18355884, 10.1016/j.taap.2008.02.005.
35. Papi A, Casoni G, Caramori G, Guzzinati I, Boschetto P, Ravenna F, Calia N, Petruzzelli S, Corbetta L, Cavallesco G, et al. COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma. Thorax 2004, 59:679-681. 1747095, 15282388, 10.1136/thx.2003.018291.
36. Rennard SI. Clinical Approach to Patients with Chronic Obstructive Pulmonary Disease and Cardiovascular Disease. Proc Am Thorac Soc 2005, 2:94-100. 10.1513/pats.200410-051SF, 16113475.
37. Kodavanti UP, Schladweiler MC, Ledbetter AD, Watkinson WP, Campen MJ, Winsett DW, Richards JR, Crissman KM, Hatch GE, Costa DL. The Spontaneously Hypertensive Rat as a Model of Human Cardiovascular Disease: Evidence of Exacerbated Cardiopulmonary Injury and Oxidative Stress from Inhaled Emission Particulate Matter. Toxicol Appl Pharmacol 2000, 164:250-263. 10.1006/taap.2000.8899, 10799335.
38. Barth P, Koch S, Muller B, Unterstab F, von Wichert P, Moll R. Proliferation and number of Clara cell 10 kDa protein (CC10)-reactive epithelial cells and basal cells in normal, hyperplastic and metaplastic bronchial mucosa. Virchows Arch 2000, 437:648-655. 10.1007/s004280000316, 11193477.
39. Schlage WK, Bulles H, Friedrichs D, Kuhn M, Teredesai A, Terpstra PM. Cytokeratin expression patterns in the rat respiratory tract as markers of epithelial differentiation in inhalation toxicology. II. Changes in cytokeratin expression patterns following 8 day exposure to room-aged cigarette sidestream smoke. Toxicol Pathol 1998, 26:344-360. 10.1177/019262339802600308, 9608640.
40. Wikenheiser KA, Whitsett JA. Tumor progression and cellular differentiation of pulmonary adenocarcinomas in SV40 large T antigen transgenic mice. Am J Respir Cell Mol Biol 1997, 16:713-723.
41. Hong KU, Reynolds SD, Watkins S, Fuchs E, Stripp BR. Basal Cells Are a Multipotent Progenitor Capable of Renewing the Bronchial Epithelium. Am J Pathol 2004, 164:577-588. 1602270, 14742263.
42. Hong KU, Reynolds SD, Giangreco A, Hurley CM, Stripp BR. Clara Cell Secretory Protein-Expressing Cells of the Airway Neuroepithelial Body Microenvironment Include a Label-Retaining Subset and Are Critical for Epithelial Renewal after Progenitor Cell Depletion. Am J Respir Cell Mol Biol 2001, 24:671-681.
43. Smith KR, Uyeminami D, Kodavanti UP, Crapo JR, Chang L-Y, Pinkerton KE. Inhibition of tobacco smoke-induced lung inflammation by a catalytic antioxidant. Free Rad Biol Med 2002, 33:1106-1114. 10.1016/S0891-5849(02)01003-1, 12374622.
44. Chen X, Qin R, Liu B, Ma Y, Su Y, Yang CS, Glickman JN, Odze RD, Shaheen NJ. Multilayered epithelium in a rat model and human Barrett's esophagus: similar expression patterns of transcription factors and differentiation markers. BMC Gastroenterol 2008, 8:1. 2267197, 18190713, 10.1186/1471-230X-8-1.